Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” fourth quarter 2024 ...

Independent Advisor Alliance increased its holdings in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 13.0% in the fourth ...

A panel of immunization experts that advises the U.S. Centers for Disease Control and Prevention will convene in April after ...

Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” fourth quarter 2024 ...

AstraZeneca PLC belongs to the healthcare sector. The company develops and markets pharmaceutical products for various therapeutic classes such as gastrointestinal, cardiovascular, respiratory, cancer ...

AstraZeneca declined to comment without detailed clinical data on claims by Chinese makers of a competing experimental lung cancer drug.

AstraZeneca (AZ) has announced that its immunotherapy Imfinzi (durvalumab) has been approved by the European Commission (EC) ...

In a report released on March 17, James Gordon from J.P. Morgan maintained a Buy rating on AstraZeneca (AZN – Research Report), with a price ...

Thanks to the spending growth cap, the U.K. government in December 2024 announced that companies would need to pay a 22.9% ...

MacroGenics (NASDAQ: MGNX) Q4 2024 Earnings Call Mar 20, 2025, 4:30 p.m. ET ...

Illumina & NashBio announce Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery: San Diego Friday, March 21, 2025, 10:00 Hrs [IST] Illumina ...

The CDC's vaccine advisory meeting initially scheduled for February has been rescheduled to April 15-16 to allow public ...